A $10.5 million settlement over asbestos claims filed Tuesday might finally end the six-year bankruptcy proceedings of auto parts maker Federal-Mogul Corp.
Gateway Inc. on Tuesday voluntarily recalled about 14,000 lithium ion battery backs because they pose a potential fire hazard due to overheating, the latest in a series of products made in China that have been recalled due to safety concerns.
Seeking to avoid liability in nearly 90 lawsuits alleging injuries related to asbestos exposure, Exxon Mobil Corp. has sued the construction company that employed the workers who filed the suits.
A Johnson & Johnson subsidiary was granted a request Monday to transfer a lawsuit from Massachusetts state court to federal court in a product liability case over knee implants.
A group of Texas ambulance companies has hit Ford Motor Co. with a class action, accusing the motor giant of negligent behavior and false advertising stemming from its alleged sale of faulty medical equipment.
The slew of lawsuits launched across the U.S. alleging an oil industry “hot fuel” conspiracy were on Monday consolidated in Kansas district court.
A year after 47 miners died while working, a group of lawmakers has introduced a legislation package aimed at further stepping up mine safety by improving emergency response and rescue plans and boosting the U.S. Mine Safety and Health Administration's regulatory powers.
A Missouri woman has won $75,000 in damages after taking drug maker Wyeth-Ayerst Laboratories Co. to trial over the controversial diet pill that has cost the company $21 billion in settlements and legal fees.
The Ivory Coast is reportedly seeking an additional $460 million from Dutch oil trading company Trafigura to clean toxic waste that was illegally dumped on its shores in August 2006.
The plaintiff in the first bellwether case against Guidant Corp. is gearing up for trial, filing court documents on Monday detailing his claims over the company's allegedly defective implantable heart defibrillators.
Pet food manufacturer Menu Foods Inc. was hit with a class action in Indiana on Monday, the latest in an outpouring of litigation after pet food contaminated with melamine killed and injured animals across the United States.
The Zurich American Insurance Co. and its legal counsel were sanctioned on Monday for their conduct in a legal battle over its insurance coverage of the World Trade Center.
The U.S. Food and Drug Administration, the European Commission, and the European Medicines Agency have updated their cooperative plan for promoting public health in the United States and Europe.
More than five years after asbestos claims crippled the company, auto parts maker Federal-Mogul Corp. was back in court again Monday to present its fourth amended reorganization plan amid controversy over one of its subsidiaries.
Having lost another battle in its war over the much-maligned painkiller, Merck & Co. must pay $4 million to plaintiffs' attorneys in a New Jersey case that alleged it hid information from doctors about the heart attack risks of Vioxx.
Having been shot down previously in a bid for discovery over a new theory about Prempro in the multidistrict products liability litigation over the hormone drug, plaintiffs' attorneys have made a new bid for documents related to progestin-free products.
Forest Laboratories Inc. has urged a judge to deny the request of one of the plaintiffs in the multidistrict litigation involving blockbuster antidepressant drugs Celexa and Lexapro, arguing that time limitations prevent the addition of a Forest subsidiary to the complaint.
Williams Bailey LLP filed more product liability lawsuits than any other firm last year, targeting Fortune 500 companies in hundreds of suits, our survey of the plaintiffs bar shows.
A plaintiffs lawyer argued Monday that Dow Chemical Co., Monsanto Co. and more than 30 other chemical companies should be held liable for supplying the defoliant “agent orange” to the U.S. government during the Vietnam War.
In a potentially crippling move, a judge has thrown out the expert testimony of a doctor for the plaintiffs in the multidistrict products liability litigation over Accutane, a development that may lead to the dismissal of all cases alleging that Roche Holding AG's acne drug causes irritable bowel syndrome.